Oxytocin Did Not Improve Social Cognition and Functioning in Schizophrenia


According to a study published in the Journal of Psychiatry and Brain Science , repeated administration of intranasal oxytocin did not affect measures of social cognition and functioning in adults with schizophrenia.

The investigators of this randomized, double-blind, parallel group study sought to examine the efficacy of neuropeptide oxytocin as an adjunctive therapy to improve social cognition and social anxiety in patients with schizophrenia.